Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;36(11):1927-1936.
doi: 10.1111/jdv.18453. Epub 2022 Aug 16.

A review of nevus-associated melanoma: What is the evidence?

Affiliations
Review

A review of nevus-associated melanoma: What is the evidence?

C Dessinioti et al. J Eur Acad Dermatol Venereol. 2022 Nov.

Abstract

Cutaneous melanoma may have an adjacent nevus remnant on histological examination in 30% of cases (nevus-associated melanoma, NAM), while it may appear de novo, without a precursor lesion, in the remaining 70% of cases. Nevus-associated melanoma and the concept of acquired melanocytic nevi serving as precursors of melanoma has long been considered as a controversial topic. This controversy is, in part, due to their overall low rate of transformation to melanoma and scarce data on the natural history of progression. Another matter of debate regarded the possibility that the reported differences in NAM vs. de novo melanoma were due to an underestimation of NAM in thicker lesions due to obliteration of the nevus component by the tumour. During the last few years, several evidence has accumulated in order to address these controversies. In this review, we present a comprehensive synthesis of the epidemiological, clinical, dermoscopic and genetic findings in NAM, including thin NAM, compared to de novo melanoma. Answering the questions on nevus-associated melanoma may provide further insight into the classification of these tumours and disentangle their biology and route of development from that of de novo melanoma.

PubMed Disclaimer

References

    1. Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications. J Am Acad Dermatol 2017; 77: 938-945 e934.
    1. Yeh I, Bastian BC. Melanoma pathology: new approaches and classification. Br J Dermatol 2021; 185: 282-293.
    1. Elder D, Barnhill RL, Bastian BC et al. Melanocytic tumour classification and the pathway concept of melanoma pathogenesis. In Elder DE, Massi D, Scolyer RA, Willemze R, eds. WHO Classification of Skin Tumours, Vol. 11, 4th edn. International Agency for Research on Cancer (IARC), France, 2018: 66-71.
    1. Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 world health organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med 2020; 144: 500-522.
    1. Pampena R, Lai M, Piana S, Lallas A, Pellacani G, Longo C. Nevus-associated melanoma: facts and controversies. G Ital Dermatol Venereol 2020; 155: 65-75.

LinkOut - more resources